IBA Proton Therapy System PROTEUS 235 Collision Detection Malfunction
FDA recalls 19 units of the IBA Proton Therapy System PROTEUS 235 due to occasional failures in collision detection for the Forte Robotic Patient Positioning System affecting facilities across multiple US states and internationally.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of a medical device with collision detection defects in a proton therapy system. Collision detection failure poses potential patient injury risk during robotic positioning. No reported illnesses or injuries are documented in the source material.
Plain-English summary
The IBA Proton Therapy System - PROTEUS 235 is designed to produce and deliver a proton beam for treating patients with localized tumors and radiation-susceptible conditions. The FDA has issued a Class II recall affecting 19 units distributed across US states (Illinois, Louisiana, New Jersey, Michigan, Oklahoma, Tennessee, Texas, Virginia, Washington) and international locations (Czech Republic, France, Germany, Italy, Japan, Poland, Russia, Sweden).
The Forte Robotic Patient Positioning System component of this equipment occasionally experiences temporary deactivation of its collision detection feature. Collision detection is critical for preventing the robotic positioning system from striking patients or equipment during treatment setup and beam delivery.
Healthcare facilities should verify whether their systems are affected by checking the device serial numbers against the FDA recall notice. Facilities using recalled units should contact Ion Beam Applications S.A. for remediation guidance. Patients undergoing proton therapy treatment should consult with their treatment team regarding any potential impact on their scheduled care.
The recalled product
- Product
- IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation
- Manufacturer
- Ion Beam Applications S.A.
- Affected units
- 19
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- UDI-DI: (01)05404013801138 Serial Numbers
- PAT.108 (US)
- PAT.110 (US)
- PAT.111 (FR)
- PAT.112 (US)
- PAT.113 (US)
- PAT.114 (CZ)
- PAT.115 (IT)
- SAT.116 (US)
- SAT.117 (PL)
- SAT.118 (RU)
- SAT.119 (US)
- SAT.120 (DE)
- SAT.122 (SE)
- SAT.123 (US)
- SAT.126 (US)
- SBF.101 (FR)
- SBF.103 (JP)
- SBF.104 (JP)
- SBF.105(US).
Distribution
Related recalls
Same manufacturer · Ion Beam Applications S.A.
See all →- HighIBA proton therapy system may not interrupt beam when gating fails
FDA (Devices) · 2026-03-18
- HighProton Therapy System Software Allows Safety Verification Mechanisms to Be Disabled
FDA (Devices) · 2024-09-18
- HighProton Therapy System May Continue Irradiation When Accelerator Control Parameters Out of Tolerance
FDA (Devices) · 2024-06-12
- HighProton Therapy System Recall: Safety Parameter Failures Risk Unintended Radiation
FDA (Devices) · 2024-05-01
- HighIBA Proton Therapy System Patient Positioning Can Move Unexpectedly
FDA (Devices) · 2023-11-22
Same hazard · collision detection failure
See all →- High